Amgen to buy cancer drug developer Five Prime Therapeutics for $1.9 billion
Reuters via Yahoo Finance· 26 minutes agoMarch 4 (Reuters) - Drugmaker Amgen Inc will acquire cancer drug developer Five Prime Therapeutics for about $1.9 billion, the companies said on Thursday. (Reporting by Manojna Maddipatla in Bengaluru; Editing by Arun Koyyur)
Feds: 17 charged with drug offenses in Waterbury after 10 month investigation
Connecticut Post· 7 hours agoAuthorities charged 17 people with federal drug distribution conspiracy offenses Tuesday, the result...
Drug Testing For Those On Public Assistance Advances In The Legislature
West Virginia Public Broadcasting· 10 hours agoSenate Wednesday that would require some low-income families receiving public assistance to be...
Drug Overdose Deaths Surge Among Black Americans During Pandemic
KPBS San Diego· 1 day agoScientists at the Centers for Disease Control and Prevention say fatal drug overdoses nationwide...
W.Va. House committee originates bill to take family drug courts statewide
The Huntington Herald-Dispatch· 9 hours agoNow with eight programs around the state, a West Virginia House of Delegates committee on Wednesday...
Man named Reckless took kid in crown to drug deal in NC Burger King bathroom, feds say
The News & Observer· 14 hours agoA kid wearing a cardboard crown witnessed a drug deal in the bathroom of a North Carolina Burger...
Elon Musk jokes about "Regretamine" drug, sparks gags about Dogecoin
Newsweek· 2 days agoA tweet by Elon Musk about a "new drug coming called Regretamine" has sparked a flurry of memes...
Four arrested in Minersville drug raid
The Pottsville Republican & Herald· 2 hours ago...and two others are facing lesser charges after Minersville police executed search warrants for illegal narcotics at an apartment Wednesday. 2, were...
Florida drug developer KemPharm’s ADHD treatment to hit the shelves this year, creating jobs -...
The Business Journals· 21 hours agoA local pharmaceutical firm's new ADHD drug was approved by the FDA, meaning sales can launch this...
Choice of Brand-Name Drug Over Generics Costs Medicare Nearly $2 Billion Annually
US News & World Report· 1 day agoWider use of prescription generic drugs could save Medicare nearly $2 billion a year, researchers say. The new analysis of Medicare Part D prescription drug claims for 2017 ...